La Rosa Holdings Corp. Form 8-K Summary
Business Context and Reporting Period
Company: La Rosa Holdings Corp. (Nasdaq: LRHC)
Filing Date: June 18, 2025
Reporting Period: Current Report (Event Date: June 18, 2025)
Context: The Company entered into an Amendment and Exchange Agreement with an institutional investor previously engaged in a February 2025 Securities Purchase Agreement. This filing details the exchange of incremental warrants for Series B Convertible Preferred Stock and the associated corporate governance actions.
Key Financial Metrics
Note: This Form 8-K reports a specific corporate transaction and does not contain comprehensive financial statements (e.g., revenue, net income, cash flow, or total debt).
- Existing Debt: A Senior Secured Convertible Note ("Initial Note") with an original principal amount of $5,500,000 remains outstanding.
- Transaction Value: The Investor surrendered 16 Incremental Warrants (each exercisable for up to $2,500,000 in Notes) in exchange for 6,000 shares of Series B Convertible Preferred Stock.
- Liquidity/Cash Flow: The filing text does not provide specific cash flow or liquidity metrics for the period.
Material Changes vs. Prior Period
- Capital Structure Change: Conversion of 16 Incremental Warrants into 6,000 shares of Series B Convertible Preferred Stock.
- Corporate Governance: Filing of a Certificate of Designation for the Series B Preferred Stock with the Nevada Secretary of State.
- Voting Rights: Execution of a Voting Agreement by CEO Joseph La Rosa to support shareholder approval for future conversions exceeding 19.99% of outstanding common stock.
Guidance, Outlook, and Material Terms
Series B Preferred Stock Terms
- Dividends: None.
- Voting Rights: Holders vote with Common Stockholders as a single class. Voting power is capped at the lesser of the conversion equivalent or 4.99% of outstanding Common Stock ("Maximum Percentage").
- Conversion Price: At the holder's option, either $0.25 per share or an "Alternate Conversion Price" (greater of $0.082 floor or 95% of the lowest 7-day VWAP). Conversions may be multiplied by 105% (Change of Control) or 125% (otherwise) if using the Alternate Conversion Price.
- Anti-Dilution: Full ratchet protection; Conversion Price reduces to the effective price of any subsequent dilutive issuance.
- Redemption: Company has the right to redeem all shares at the greater of the Conversion Amount or the product of the Conversion Rate and the highest Closing Sale Price during the notice period.
Shareholder Approval Requirement
Conversion of Series B Preferred Stock into Common Stock exceeding 19.99% of outstanding shares requires shareholder approval. The Company agreed to convene a stockholder meeting within 120 days of the Exchange Agreement (by approximately October 16, 2025).
Investor Verification Checklist
- Verify the exact terms of the "Alternate Conversion Price" calculation in the Certificate of Designation (Exhibit 3.1).
- Confirm the timeline for the upcoming shareholder meeting required for conversions exceeding the 19.99% threshold.
- Review the full text of the Voting Agreement (Exhibit 10.2) to understand the scope of CEO Joseph La Rosa's commitment.
- Assess the potential dilution impact given the $0.25 fixed conversion price and the full ratchet anti-dilution provision.
- Check for any subsequent filings regarding the status of the $5,500,000 Initial Note.